Targeting Mannitol Metabolism as an Alternative Antimicrobial Strategy Based on the Structure-Function Study of Mannitol-1-Phosphate Dehydrogenase in Staphylococcus aureus by Nguyen, Thanh et al.
Targeting Mannitol Metabolism as an Alternative
Antimicrobial Strategy Based on the Structure-Function Study
of Mannitol-1-Phosphate Dehydrogenase in Staphylococcus
aureus
Thanh Nguyen,a Truc Kim,a Hai Minh Ta,a Won Sik Yeo,b Jongkeun Choi,c Pushpak Mizar,d Seung Seo Lee,d Taeok Bae,b
Akhilesh Kumar Chaurasia,a Kyeong Kyu Kima,e
aDepartment of Molecular Cell Biology, Institute for Antimicrobial Research and Therapeutics, Sungkyunkwan University School of Medicine, Suwon, South Korea
bDepartment of Microbiology and Immunology, Indiana University School of Medicine Northwest, Gary, Indiana, USA
cDepartment of Chemical Engineering, Chungwoon University, Incheon, South Korea
dSchool of Chemistry, University of Southampton, Southampton, United Kingdom
eSamsung Biomedical Research Institute, Samsung Advanced Institute for Health Sciences and Technology, Samsung Medical Center, Sungkyunkwan University School
of Medicine, Seoul, South Korea
ABSTRACT Mannitol-1-phosphate dehydrogenase (M1PDH) is a key enzyme in
Staphylococcus aureus mannitol metabolism, but its roles in pathophysiological set-
tings have not been established. We performed comprehensive structure-function
analysis of M1PDH from S. aureus USA300, a strain of community-associated
methicillin-resistant S. aureus, to evaluate its roles in cell viability and virulence un-
der pathophysiological conditions. On the basis of our results, we propose M1PDH
as a potential antibacterial target. In vitro cell viability assessment of ΔmtlD knockout
and complemented strains conﬁrmed that M1PDH is essential to endure pH, high-
salt, and oxidative stress and thus that M1PDH is required for preventing osmotic
burst by regulating pressure potential imposed by mannitol. The mouse infection
model also veriﬁed that M1PDH is essential for bacterial survival during infection. To
further support the use of M1PDH as an antibacterial target, we identiﬁed dihydro-
celastrol (DHCL) as a competitive inhibitor of S. aureus M1PDH (SaM1PDH) and con-
ﬁrmed that DHCL effectively reduces bacterial cell viability during host infection. To
explain physiological functions of SaM1PDH at the atomic level, the crystal structure
of SaM1PDH was determined at 1.7-Å resolution. Structure-based mutation analyses
and DHCL molecular docking to the SaM1PDH active site followed by functional as-
say identiﬁed key residues in the active site and provided the action mechanism of
DHCL. Collectively, we propose SaM1PDH as a target for antibiotic development
based on its physiological roles with the goals of expanding the repertory of antibi-
otic targets to ﬁght antimicrobial resistance and providing essential knowledge for
developing potent inhibitors of SaM1PDH based on structure-function studies.
IMPORTANCE Due to the shortage of effective antibiotics against drug-resistant
Staphylococcus aureus, new targets are urgently required to develop next-generation
antibiotics. We investigated mannitol-1-phosphate dehydrogenase of S. aureus
USA300 (SaM1PDH), a key enzyme regulating intracellular mannitol levels, and ex-
plored the possibility of using SaM1PDH as a target for developing antibiotic. Since
mannitol is necessary for maintaining the cellular redox and osmotic potential, the
homeostatic imbalance caused by treatment with a SaM1PDH inhibitor or knockout
of the gene encoding SaM1PDH results in bacterial cell death through oxidative
and/or mannitol-dependent cytolysis. We elucidated the molecular mechanism of
SaM1PDH and the structural basis of substrate and inhibitor recognition by enzy-
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matic and structural analyses of SaM1PDH. Our results strongly support the concept
that targeting of SaM1PDH represents an alternative strategy for developing a new
class of antibiotics that cause bacterial cell death not by blocking key cellular ma-
chinery but by inducing cytolysis and reducing stress tolerance through inhibition of
the mannitol pathway.
KEYWORDS mannitol-1-phosphate dehydrogenase, Staphylococcus aureus, antibiotic
target, antimicrobial resistance, crystal structure, inhibitor, mannitol, virulence
Many antibiotics that have been used for the treatment of Staphylococcus aureusinfections are becoming ineffective because of the development of antimicrobial
resistance (AMR) (1–4). The emergence of AMR in S. aureus strains necessitates identi-
fying novel antibiotic targets and the corresponding interacting drug molecules. In
general, a signiﬁcant number of antibiotics inhibit the key cellular machinery by
targeting the components associated with replication, transcription, and protein trans-
lation (5). On the other hand, -lactam antibiotics target bacterial cell wall biosynthesis
(6). The cell wall is important for governing bacterial shape, size, and integrity by
regulating the pressure potential (P) and mechanochemical properties of cells (7). The
solute (organic and inorganic) homeostasis system is also responsible for maintaining
cellular integrity by counteracting external osmotic pressure against various forms of
pathophysiological stresses (8, 9). Accordingly, switching between the anabolism and
catabolism of organic solutes is closely linked to stress adaptation and virulence (9).
Intracellular mannitol is the product of glucose metabolism and has been reported
to play essential roles as a compatible solute in osmoprotection in bacteria Glucono-
bacter oxydans, Pseudomonas putida, Acinetobacter baylyi, and Staphylococcus aureus
(10–13). Mannitol is one of the most abundant examples of a six-carbon polyol, which
controls osmotic pressure and cellular redox (e.g., reactive oxygen species [ROS]) in
plants and fungi (14, 15). The intracellular mannitol level is known to inﬂuence heat and
osmotic stress tolerance, virulence, and pathogenicity in fungal pathogens (16–18). The
mannitol pathway is present in plants, fungi, and some bacteria (14, 19, 20). However,
studies on such an “intracellular mannitol pool” and its direct correlation with “osmo-
protection, ROS tolerance, and virulence” in bacteria are lacking. Recently, the role of
mannitol in potentiation of antimicrobial lipid (21) and of gentamicin in effective
eradication of methicillin-resistant S. aureus (22) has been reported. From these points
of views, the dysregulation of the pressure potential (P) or mechanochemical prop-
erties of bacteria through hampering auxiliary metabolic pathways such as the man-
nitol pathway seems to be an attractive strategy to develop next-generation antibiotics.
The mannitol metabolism cycle mediates the interconversion of fructose-6-phosphate
(F6P) to mannitol and vice versa in the glycolytic pathway (13). Conventionally, F6P is
converted to mannitol-1-phosphate (M1P) by the NADH-dependent mannitol-1-
phosphate dehydrogenase (M1PDH), and then M1P is dephosphorylated to mannitol
by the M1P phosphatase (M1PP), which is necessary for maintaining osmotic pressure.
In the reverse reaction, NAD-dependent mannitol-2-dehydrogenase (M2DH) converts
mannitol to fructose, which is then phosphorylated by fructokinase to generate F6P to
enter into energy metabolism (15) (Fig. 1A).
In bacteria, the mtl operon commonly consists of three or four genes, namely, mtlA,
mtlR, mtlF, and mtlD, coding for phosphoenolpyruvate-dependent mannitol-speciﬁc
phosphotransferase system (PTS) enzyme II BC component, a transcriptional activator,
an PTS enzyme II A component, and a mannitol dehydrogenase, respectively (Fig. 1B).
Thus, mtlD is the only gene coding for a single mannitol dehydrogenase enzyme,
M1PDH or M2DH, suggesting that the mannitol pathways in bacteria do not follow the
conventional mannitol pathway that is present in various plants and fungi (14, 19, 20).
M2DHs from many bacteria have been studied for their enzymatic activity, biochemical
substrates, and structure (23–25). S. aureus USA300 possesses an M1PDH instead of
M2DH. However, the functional role of mannitol metabolism in bacterial pathogenesis
and the validity of the mannitol pathway as an antibacterial target have not been
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established and remain to be explored. Furthermore, due to the absence of M2DH in
S. aureus, S. aureusM1PDH (SaM1PDH) appears to be the only enzyme that converts F6P
to M1P and vice versa (Fig. 1B); thus, mannitol metabolism in S. aureus is expected to
differ signiﬁcantly from the conventional pathway. From this point of view, we hypoth-
esized that SaM1PDH might have prominent, novel biochemical and physiological roles
in S. aureus pathogenicity.
In this study, we established the status of SaM1PDH as a new antibacterial target by
verifying that a knockout strain of S. aureus USA300 lacking the functional gene
encoding M1PDH (mtlD) was cytolyzed by mannitol treatment and showed a reduction
in stress tolerance and virulence. We also assessed the mechanistic details of how the
intracellular mannitol level is modulated by SaM1PDH in response to extracellular pH,
osmotic, and oxidative stresses, which is essential for the pathogen’s defense against
stresses imposed by host during infection. Furthermore, we identiﬁed the small-
molecule inhibitor of SaM1PDH that effectively reduced the survival of S. aureus
USA300 in macrophages. The crystal structure of SaM1PDH, solved at 1.7-Å resolution,
revealed critical residues for substrate recognition and established structural models for
substrate and inhibitor binding. Taking the results together, this report not only
provides a description of the molecular basis of the structure, reaction mechanism,
substrate speciﬁcity, and pathophysiological functions of SaM1PDH but also identiﬁes
a potent inhibitor of M1PDH. These results contribute to a new approach to eradication
of MRSA infections.
RESULTS
Stress modulation by M1PDH in S. aureus USA300. Under pathophysiological
conditions, S. aureus experiences various stresses. To understand the functional role of
M1PDH in S. aureus (SaM1PDH) under these conditions, we compared the physiologies
of wild-type (WT) S. aureus USA300, the corresponding mutant strain (mtlDerm
resistance [mtlDermr] mutant) lacking the functional gene encoding M1PDH (mtlD),
and a mutant complemented strain (mtlDermr_mtlD) under normal, high-salt, and
FIG 1 Mannitol metabolism pathway and the mannitol operon in bacteria. (A) A conventional mannitol metabolism pathway. (Adapted from reference 18 with
permission.) Extracellular mannitol is taken up by a membrane anchoring the mannitol-speciﬁc phosphotransferase system (PTS) as M1P. M1P is then either
dephosphorylated by mannitol-1-phosphate phosphatase (M1PP) to generate an intracellular mannitol pool in the bacterial cells or converted to F6P by
NAD-dependent oxidase activity of M1PDH. F6P can be either directed to the glycolytic pathway or dephosphorylated by hexokinase (HXK) to generate
fructose. Fructose is then converted to mannitol by the NADH-dependent reductase activity of M2DH. In the reverse reaction, F6P is converted to M1P by
NADH-dependent reductase activity of M1PDH. M1P is further dephosphorylated by M1PP to generate mannitol stored in the cell to act as a compatible solute.
Intracellular mannitol can be converted to fructose by the NAD-dependent oxidase activity of M2DH and further phosphorylated by HXK to generate F6P,
which enters the glycolytic pathway. (B) The occurrence of the mannitol operon in a wide range of bacterial genera. Data show the organization of the mannitol
operon in Staphylococcus aureus (NC_007793.1), Bacillus subtilis (CP020102.1), Clostridium acetobutylicum (U53868), Escherichia coli (U00096.3), and Klebsiella
pneumoniae (FO834906.1).
M1PDH as a Novel Antimicrobial Target ®
July/August 2019 Volume 10 Issue 4 e02660-18 mbio.asm.org 3
alkaline pH stress conditions. Under normal growth conditions in brain heart infusion
(BHI) media, these strains showed similar growth proﬁles (see Fig. S1 in the supple-
mental material). Intriguingly, the mtlDermr strain showed signiﬁcant growth defects
under both pH and salt stress conditions, whereas the corresponding complemented
strain overcame such growth defects (Fig. 2A; see also Fig. S1).
To corroborate the physiological data, we further investigated mtlD expression
levels under conditions of mannitol, pH, and salt stresses and mtlD cotranscription with
genes coding for the mannitol-speciﬁc PTS (mtlA and mtlF) and veriﬁed the phenotypic
traits of PTS mutants mimicking the susceptibility of the mtlDermr mutant. First, we
performed quantitative reverse transcription PCR (qRT-PCR) to assess the levels of
expression of individual genes involved in mannitol metabolism (mtlA, mtlR, mtlF, and
mtlD) under mannitol, salt, and alkaline stress conditions (Fig. S2A). As expected, the
supplementation of mannitol induced the expression of mtlD by 1.8-fold (Fig. S2A). The
abundance of all transcripts from genes mtlA, mtlR, mtlF, and mtlD involved in mannitol
metabolism under conditions of salt and alkaline stresses was signiﬁcantly reduced
compared to those of the corresponding controls (Fig. S2A). The change in pH is known
FIG 2 Stress modulation by M1PDH in S. aureus USA300. (A) Effects of abiotic stresses (pH and salt) on the growth of S. aureus USA300
strains. Bacterial growth was assessed by CFU assay at 37°C for 15 h in (left) BHI media adjusted to a pH of 10.0 and (right) BHI media
supplemented with 0.2 M NaCl in 96-well plates. (B) Accumulations of intracellular mannitol in S. aureus USA300 strains under various
stress conditions. The indicated bacterial strains were cultured in either BHI media (control [Ctrl]) or modiﬁed BHI media mimicking
stress conditions (pH 10.0, 0.2 M NaCl, and 27.5 mM mannitol). Intracellular mannitol was then extracted from 100 mg of cell pellets
and quantiﬁed, and levels were calculated as percentages in S. aureus USA300 strains grown under various conditions compared to
that of the WT strain grown in control media. (C) Effect of mannitol on Triton X-100-induced autolysis of S. aureus USA300 strains. After
cells were cultured in either (left) BHI media or (right) BHI media containing 27.5 mMmannitol, bacterial cell densities of all strains were
adjusted to an OD600 of 0.9 in PBS containing 0.05% Triton X-100, and survival of each strain was monitored at room temperature for
12 h by the CFU assay. (D) Effect of mannitol on the cell size of S. aureus USA300 examined by scanning electron microscope (SEM).
After being cultured at 37°C in either BHI media or BHI media containing 5 mM mannitol for 48 h, WT and SaM1PDH knockout
(mtlDermr) S. aureus USA300 strains were harvested, processed, and visualized under a SEM. From SEM photographs, 40 to 100 cells
from each strain were randomly selected for diameter measurements. SEM photographs are shown under a graph of relative bacterial
cell diameters versus S. aureus strains with or without mannitol treatment. For the graph in panel D, data are presented as medians
(horizontal lines) with interquartile ranges (whiskers), whereas for the other graphs, data are presented as means  standard
deviations of the means. Statistical signiﬁcance was calculated by Student’s t test (*, P 0.05; **, P 0.01; ***, P 0.001).
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to decrease PTS transcript levels signiﬁcantly in S. aureus (26). Second, we compared the
expression level ofmtlD with that ofmtlA,mtlR, andmtlF in individualmtl-speciﬁc bursa
aurealis transposon mutants of S. aureus USA300 (27) (Fig. S2B). Expression of genes
mtlA, mtlR, and mtlF located upstream of mtlD was found to be induced in the
mtlDermr mutant, while mtlD expression was repressed in the individual mutants of
mtlAermr,mtlRermr, andmtlFermr (Fig. S2B). These results showing that expression
of mtlD correlated with expression of mtlA, mtlR, and mtlF under all tested stress
conditions (Fig. S2A) and that mtlD transcription was downregulated in the individual
mutants (mtlAermr, mtlRermr, and mtlFermr) with mutations in the mtl operon
suggest thatmtlD is cotranscribed with the genes corresponding to themtl-speciﬁc PTS
(mtlA and mtlF) and its regulator (mtlR). In addition, the footprinting data determined
previously for the mtlARFD operon in Bacillus stearothermophilus (28) conﬁrmed the
promoter region. Interestingly, the promoter region of B. stearothermophilus showed
high sequence similarities with that of B. subtilis and S. carnosus (28) along with the
predicted promoter region of the mtlARFD operon in S. aureus USA300 (Fig. S2C).
Third, we carried out the phenotypic assessment of mannitol PTS mutants using the
mannitol catabolism assay and of the alkalinity stress response by CFU enumeration.
Both the mtlAermr PTS mutant and the mtlFermr PTS mutant showed an inability to
perform mannitol catabolism, similarly to that observed in the mtlDermr mutant
(Fig. S2D). Furthermore, to assess the essentiality and role of the individual genes, we
supplemented the individual mutants (strains mtlAermr, mtlRermr, mtlFermr, and
mtlDermr) with plasmid pRMC2_mtlD encoding wild-type SaM1PDH. Interestingly,
only the mtlFermr strain supplemented with pRMC2_mtlD could recover the mannitol
catabolism, though it did so at slightly lower efﬁciency than was seen with the
mtlDermr mutant complemented with pRMC2_mtlD (Fig. S2D). The recovery of man-
nitol metabolism shown by the mtlFermr mutant supplemented with pRMC2_mtlD
encoding SaM1PDH enzyme suggests that (i) mtlA is the major component of the PTS
in S. aureus USA300 and that (ii) mtlF appears to be a synonymous redundant gene in
the mannitol uptake PTS. The analysis of the mtl operon showed that the mtlF gene is
usually absent in various Gram-negative bacterial species, which could further support
the idea of the redundancy of mtlF in Gram-positive bacteria (Fig. 1B). To further assess
and compare the levels of sensitivity to alkalinity stress, we compared the susceptibility
of mtlAermr and mtlFermr PTS mutants with that of the mtlDermr mutant under an
alkaline condition (Fig. S2E). Consistent with mannitol metabolism (Fig. S2C), both the
mtlAermr and mtlFermr PTS mutants showed susceptibility similar to that shown by
the mtlDermr mutant (compared to the WT S. aureus strain) under alkaline stress
conditions (Fig. S2E). The comparable levels of survival of the mtlFermr_mtlD strain
(i.e., the mtlFermr mutant supplemented with pRMC2_mtlD) and of the
mtlDermr_mtlD strain (mtlDermr mutant complemented with pRMC2_mtlD) and the
WT strain (WT or WT with empty vector pRMC2) further demonstrated that the PTS
enzyme II BC (MtlA) component is the major component of the mannitol-speciﬁc PTS
(Fig. S2E). Taking these results together, it was evident that the PTS is essential for
extracellular mannitol uptake whereas the M1PDH enzyme plays the key role in
mannitol metabolism to modulate and alleviate the stress response in S. aureus
USA300.
Since mannitol metabolism is directly linked to cellular pH and osmotic pressure, we
compared the relative mannitol levels spectrophotometrically (A412) in the WT and
SaM1PDH knockout strains and the corresponding complemented strains under pH
and salt stress conditions (Fig. 2B). In this experiment, we saw that the mannitol level
in the knockout strain (mtlDermr) was lower than those in the WT and complemented
strains under control, pH, and salt stress conditions (Fig. 2B), suggesting that mannitol
was neither consumed nor synthesized in the SaM1PDH-deﬁcient strain. On the other
hand, the intracellular mannitol level was much higher in the WT or complemented
strains than in the knockout strain under all tested conditions except mannitol
supplementation conditions (Fig. 2B). Intriguingly, during growth in mannitol-
supplemented media, the level of mannitol was found to be the highest in the
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mtlD-knockout strain, presumably because the continuous import of mannitol and the
accumulated mannitol were not catabolized (Fig. 2B). Consistent with the results
analyzed by UV-visible light (UV-Vis) spectrometry, the higher mannitol level in the WT
strain than in the mutant strain was further conﬁrmed by gas chromatography-mass
spectrometry (Fig. S3A). In addition, the S. aureus strain with no SaM1PDH activity
(mtlDermr) exposed to the mannitol-containing medium showed induction of the mtl
operon at the transcriptional level (Fig. S2A and B). These results indicate that the
accumulation of intracellular mannitol in the mtlDermr knockout strain is a synergistic
effect of increased mannitol uptake resulting from induced expression of the PTS and
of no catabolic activity under conditions of accumulated mannitol due to the absence
of SaM1PDH in the mtlDermr knockout strain. Hence, it could be seen that SaM1PDH
is indeed indispensable for the homeostasis of intracellular mannitol under various
stress conditions.
Maintenance of cell wall integrity by M1PDH in S. aureus USA300. Homeostasis
of compatible solutes is known to be related to the turgor and osmotic pressures that
control cell shape and wall integrity (9). Thus, the issue was whether the presence of
SaM1PDH was necessary for the cell wall integrity through controlling the level of
mannitol, one of representative compatible solutes. The mtlDermr knockout strain
cultured for 48 h on the solid media in the presence of mannitol formed bigger and
more translucent colonies than the WT strain (Fig. S3B and C), suggesting that the
intracellular accumulation of mannitol possibly affected the colony phenotype and
arguably altered the shape, size, and wall integrity of the individual cells. Thus, to
explore this result in detail, we investigated the contribution of SaM1PDH to the cell
wall strength by comparing the levels of Triton X-100-induced cytolysis of the WT,
knockout, and complemented strains. The bacteria cultured in the absence and pres-
ence of optimized 27.5 mM mannitol for 48 h were subjected to the cytolysis assay
(Fig. 2C; see also Fig. S3D). On the basis of the results of this assay, we conﬁrmed that
the cytolysis rates of the WT and complemented strains were lower than that of the
knockout strain in the absence of mannitol, suggesting that the cell wall of the mutant
strains was much weaker than the cell walls of the WT and complemented strains
(Fig. 2C, left; see also Fig. S3D, left). This phenomenon was found to have accelerated
when cells were cultured in the mannitol-containing medium (Fig. 2C, right; see also
Fig. S3D, right). In contrast, the cytolysis rates of the WT and complemented strains
were not signiﬁcantly changed in the mannitol-containing medium (Fig. 2C; see also
Fig. S3D).
The swelling and subsequent cytolysis of the SaM1PDH knockout strain in the
presence of mannitol were further examined by visualizing the phenotypic alteration of
bacteria using scanning electron microscopy (SEM) (Fig. 2D). For SEM analysis, the WT
and knockout strains were cultured for 48 h in BHI media with and without mannitol
supplementation. The knockout cells grown in the media without mannitol were
approximately 11% bigger than the WT cells, suggesting that the mutant cells were
slightly swollen even in the absence of mannitol (Fig. 2D). When the knockout cells
were grown in mannitol-containing media, they either burst or were signiﬁcantly
enlarged in size by 31% compared to the WT cells grown under identical culture
conditions, due to mannitol accumulation and consequent inﬂow of water (Fig. 2D).
Furthermore, we compared the levels of membrane permeability of the WT and
mtlDermr strains and the corresponding complemented strains without or with
mannitol by dual staining using wheat germ agglutinin (WGA)-Alexa Fluor 488 conju-
gate (green) and propidium iodide (PI) (red). WGA stains the cell wall of S. aureus, while
PI speciﬁcally enters cells with a damaged cell membrane (29). Consistent with the SEM
results, negligible numbers of PI-positive S. aureus cells were observed in all strains
without mannitol, suggesting that all three strains (i.e., the WT, mtlDermr, and mutant
complemented strains) were healthy under normal growth conditions (Fig. S3E). In
contrast, a signiﬁcantly high number of S. aureus cells in themtlDermr knockout strain
showed PI-positive staining whereas most of the WT and complemented S. aureus cells
Nguyen et al. ®
July/August 2019 Volume 10 Issue 4 e02660-18 mbio.asm.org 6
showed PI-negative staining. These results showed that the membrane integrity of the
mtlDermr knockout strain lacking SaM1PDH activity was indeed compromised under
the conditions that included mannitol supplementation, facilitating cytolysis. Taking
these results together, we propose that SaM1PDH plays a key role in maintaining the
osmotic pressure and cell wall integrity of S. aureus USA300 by controlling the intra-
cellular mannitol level. Therefore, it can be expected that inhibiting SaM1PDH would
cause swelling and mannitol-induced cytolysis.
Antivirulence phenotypes by targeting M1PDH. We demonstrated that M1PDH
deﬁciency in S. aureus USA300 in the presence of mannitol or under salt stress
conditions led to bacterial susceptibility and subsequent death (Fig. 2). However, under
in vivo infection conditions, such a radical change in the mannitol/salt level is unlikely
to occur. Nevertheless, even under normal conditions, SaM1PDH deﬁciency-mediated
bacterial susceptibility may help to impede the evasion mechanism of S. aureus
USA300. To test this hypothesis, we performed a bacterial infection experiment using
the RAW 264.7 mouse macrophage cell line in the absence and presence of mannitol
in the culture media (Fig. 3A; see also Fig. S4A and B). RAW 264.7 cells were infected
FIG 3 Role of SaM1PDH and effect of mannitol on S. aureus USA300 virulence. (A) Role of SaM1PDH and effect of
mannitol on S. aureus USA300 survival rate in macrophages. After infections by WT, mtlDermr, and
mtlDermr_mtlD S. aureus strains followed by removal of extracellular bacteria, infected RAW 264.7 cells were
cultured in either control media or media containing 2.75 mM mannitol for 6 h. CFU levels of internalized bacteria
were determined by plating infected RAW 264.7 cell lysates onto the BHI agar. (B) Effect of ROS on intracellular
mannitol levels in S. aureus USA300 strains. The indicated bacterial strains were cultured in either BHI media
(control [Ctrl]) or BHI media containing ROS-generating chemicals (H2O2, FeSO4, and NaI). Intracellular mannitol was
then extracted and quantiﬁed, and the levels were calculated as percentages of mannitol in S. aureus USA300
strains grown in media containing ROS-generating chemicals compared to that of the WT strain grown in control
media. For panels A and B, data were obtained from three independent experiments and are presented as
means  standard deviations of the means. Statistical signiﬁcance was calculated by Student’s t test (*, P 0.05;
***, P 0.001; NS, not signiﬁcant). (C and D) Role of SaM1PDH in and effect of mannitol on pathogenicity of S.
aureus USA300 strains in the murine model of systemic infection. Following retro-orbital injection of either WT or
knockout (mtlDermr) S. aureus strains into C57BL/6 mice (n 15), either PBS or PBS containing mannitol was
injected intravenously into these mice at 12-h intervals. (C) A Kaplan Meier plot of mouse survival for each
treatment over 8 days was constructed, and statistical signiﬁcance was calculated by the log rank test (*, P 0.05;
**, P 0.01), Then the surviving mice were subjected to isolation of organs followed by homogenization of the
organs in PBS. (D) The colorization of the bacteria in indicated organs was quantiﬁed by the CFU assay, and
statistical signiﬁcance was calculated using the F-test (*, P 0.05; **, P 0.01; ***, P 0.001).
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with the WT, knockout, and complementation strains at a multiplicity of infection (MOI)
of 100 (30–32). The in vitro infection results obtained using modiﬁed gentamicin
protection assays (GPA) (Fig. 3A) were validated by enzyme protection assays (EPA)
(Fig. S4A) wherein the host cell-impermeable lysostaphin enzyme was used as a
bacterium-killing agent (33). Enzyme protection assays were applied to avoid any
nonspeciﬁc killing of intracellular S. aureus due to gentamicin internalization during the
GPA (33–35). Compared to that of the WT and complemented strains, the susceptibility
of the internalized mtlD-knockout strain was found to be signiﬁcantly increased in both
the GPA and EPA (50% and34% in the GPA and 56% and46% in the EPA) (Fig. 3A;
see also Fig. S4A). Both the lysostaphin-based and gentamicin-based protection assays
showed comparative susceptibility results similar to those shown by the respective
controls. These results suggested that SaM1PDH plays a signiﬁcant role in the intra-
cellular survival of S. aureus USA300. This increased susceptibility of the knockout strain
was accelerated (95% and92% GPA;85% and80% EPA) when cells were treated
with 2.75 mM mannitol (Fig. 3A; see also Fig. S4A).
Professional phagocytic cells (macrophages) generate reactive oxygen species (ROS)
to kill internalized bacteria by oxidative burst (36). Moreover, mannitol is known to be
a powerful scavenger for hydroxyl radicals (37); thus, it plays a vital role for many
pathogenic fungi in their defense against host ROS stress (38). In addition, SaM1PDH
was reported to help S. aureus overcome hydrogen peroxide (H2O2) stress (21). We
therefore predicted that the increased susceptibility of the internalized knockout strain
in RAW 264.7 was the synergistic effect of a weakened ROS defense system and
debilitated cell wall. To substantiate this, an infection experiment was performed in the
presence of an ROS inhibitor, N-acetyl-L-cysteine (NAC) (Fig. S4B). In this experiment, it
was shown that the addition of NAC enhanced intracellular survival of all three S. aureus
strains. The survival rates of the WT and complemented strains were increased about
3	 whereas the survival of the knockout strain was increased 5	, indicating that the
knockout strain was more sensitive to ROS and thus that inhibition by NAC was more
pronounced. This suggests that SaM1PDH highly likely contributes to ROS resistance of
S. aureus during infection (Fig. S4B). In addition, the survival rates of WT and knockout
strains were compared by the dilution spotting assay using BHI agar plates containing
a hydroxyl radical generating system (100 M H2O2 plus 10 M FeSO4 plus 10 M NaI)
(39) to assess the ROS susceptibility resulting from SaM1PDH deﬁciency (Fig. S4C). The
SaM1PDH knockout strain (mtlDermr mutant) was 100-fold more susceptible to ROS
stress than the WT S. aureus strain (Fig. S4C). Consistent with our results, susceptibility
of the mtlDermr mutant under conditions of hydrogen peroxide treatment has
previously been reported by Kenny et al. (21). Interestingly, the hydroxyl radical
exposure resulted in slight (33%) accumulations of mannitol in the WT and comple-
mented strains (Fig. 3B) but not in the knockout strain, which plausibly indicates that
ROS treatment enhanced the intracellular mannitol level. These results suggest that
SaM1PDH plays a role in the virulence of S. aureus USA300 by controlling mannitol
biosynthesis for the defense against ROS produced by host immune cells and thus that
S. aureus USA300 can gain survival advantages in the host.
We further explored these observations in a mouse infection model. Mice were
infected with 2	 107 CFU of the WT strain or the knockout strains via retro-orbital
injection, and either phosphate-buffered saline (PBS) or mannitol was injected into
mice every 12 h postinfection for 8 days. Mice infected with WT S. aureus USA300 and
subsequent injected with either PBS or mannitol died at average rates of 30% and 50%,
respectively (Fig. 3C). In contrast, none of the mice that were infected with the
knockout strain died after either PBS or mannitol treatment (Fig. 3C). These results
implied that SaM1PDH is important for bacterial pathogenicity. Unexpectedly, although
the difference did not reach statistical signiﬁcance, the administration of mannitol
increased the death rate of mice infected with the WT strain from 30% to 50% (Fig. 3C),
indicating that the presence of mannitol could also affect staphylococcal pathogenesis.
However, the effect of mannitol in the mutant strain could not be evaluated by this
infection model since the death rate was zero under both sets of conditions (Fig. 3C).
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Subsequently, the differences in the rates of bacterial colonization of WT and knockout
strains in liver and kidney were compared (Fig. 3D). The colonization rates of the WT
and knockout strains were quantiﬁed by the CFU assay. The survival rates of the
knockout strain in liver were reduced about 103-fold and 104-fold under mannitol-
deﬁcient and mannitol supplementation conditions, respectively (Fig. 3D). Consistently,
the survival rate of the knockout strain in kidney under the mannitol supplementation
was reduced signiﬁcantly (about 15-fold) compared to that of the WT strain, which
showed no change under the mannitol-deﬁcient conditions (Fig. 3D). These results
suggest that the mannitol metabolism affected staphylococcal pathogenesis; wherein
M1PDH plays a key role in mannitol homeostasis and plausibly acts as a molecular
switch between the normal bacterial physiology and pathophysiology. Taking the
results together, we propose SaM1PDH as a new target for developing the next
generation of antibacterial therapeutics with two parallel attributes: (i) an antivirulence
approach involving inhibition of SaM1PDH to accelerate the efﬁciency of ROS-mediated
killing by host cells and (ii) an antibacterial approach involving inhibition of SaM1PDH
to weaken the cell wall through an imbalance in mannitol metabolism and consequent
cytolysis.
A small-molecule inhibitor of SaM1PDH reduced the infection potential of S.
aureus USA300. To test the feasibility of developing small-molecule inhibitors target-
ing SaM1PDH, a preliminary screening of the chemical libraries was performed using
mannitol fermentation assays in mannitol phenol red broth media (Fig. 4A; see also
Fig. S5A). The primary hits inhibiting mannitol fermentation were further validated in a
secondary screening using a F6P reductase activity assay (Fig. S5B), by which we
identiﬁed dihydrocelastrol (DHCL) as a potent inhibitor of SaM1PDH. Kinetic inhibitory
studies using various F6P and DHCL concentrations conﬁrmed that DHCL was a
competitive inhibitor of SaM1PDH with a Ki of 4.0 M (Fig. 4B; see also Table 1),
indicating that DHCL bound to the active site in direct competition with substrates.
Next, the effect of DHCL on the virulence of S. aureus USA300 was investigated using
the murine macrophage infection model. Infected RAW 264.7 cells were cultured in
media with or without 2.75 mM mannitol and treated with increasing concentrations (0
to 2.0 M) of DHCL or with dimethyl sulfoxide (DMSO) as a control. The concentration
range of DHCL was determined on the basis of the concentration of DHCL that should
not affect the growth of either the bacterial cells or the host cells (noninhibitory
concentration [NIC]; see Fig. S5C). Even in the absence of mannitol, DHCL treatment
reduced the number of surviving intracellular bacteria in a concentration-dependent
manner. Moreover, in the presence of mannitol, the effect of 2.0 M DHCL on S. aureus
USA300 elimination was augmented by approximately 3-fold (Fig. 4C). From these
results, we demonstrated that a small-molecule inhibitor of SaM1PDH was able to exert
similar effects with respect to the knockout of mtlD and, subsequently, that the
identiﬁed inhibitor, DHCL, was capable of use as an antimicrobial drug targeting
SaM1PDH.
Molecular mechanism of stress modulation by SaM1PDH. In S. aureus, the
interconversion between M1P and F6P is performed by M1PDH. Therefore, the steady
states of the enzymatic reactions are expected to be controlled by cellular physico-
chemical parameters such as the intracellular pH (pHi), salinity, or redox status of the
cells as observed in physiological studies (Fig. 2; see also Fig. 3). To corroborate the
physiological functions of SaM1PDH at the molecular level, we performed biochemical
assessments. First, the dehydrogenase and reductase activities of SaM1PDH were
examined under the aforementioned physiological conditions to elucidate enzyme
directionality. For this purpose, we measured the kinetic parameters of the dehydro-
genase and reductase activities using M1P/NAD and F6P/NADH, respectively, at pH 7
(Fig. S6A and B). The kcat and Km values for the reduction of F6P were found to be
2,540 30 s
1 and 88.6 3.4 M, respectively, whereas the corresponding values for
the oxidation of M1P were 16.8 0.6 s
1 and 188 13 M, respectively. These data
indicated that the rate of F6P reduction was about 150-fold higher than the rate of M1P
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oxidation. Moreover, the apparent substrate afﬁnity for F6P was 2-fold higher. There-
fore, the kcat/Km value for F6P (28.7 M
1 s
1) was approximately 321-fold higher than
the kcat/Km value for M1P (8.94	 10
2M
1 s
1) at neutral pH (Fig. S6A and B). This
result implies that SaM1PDH works as a F6P reductase enzyme under physiological
conditions, and thus the synthesis of M1P is preferred.
Second, to understand the molecular basis of the mannitol depletion in the WT
strain (Fig. 2B) at higher pH, we examined the oxidoreductase activities of SaM1PDH at
various levels of pH (5.0 to 11.5) (Fig. 5A). Under our experimental conditions, SaM1PDH
FIG 4 Identiﬁcation of dihydrocelastrol (DHCL) as a potent SaM1PDH inhibitor. (A). Schematic diagrams illustrating (left) a screening
strategy to identify small-molecule inhibitors of SaM1PDH and (right) the expected mode of action of identiﬁed SaM1PDH inhibitors
in S. aureus USA300 pathophysiology. (B) Competitive inhibitory effect of DHCL on F6P reductase activity of SaM1PDH. Initial rates of
SaM1PDH F6P reduction reactions at various DHCL concentrations (0 to 20 M) were calculated by measuring changes in absorbance
of NADH at 340 nm. A double reciprocal Lineweaver-Burk plot of initial reaction rates versus F6P concentrations was constructed at
each DHCL concentration for calculating the inhibition kinetic parameters. Dots represent data points averaged from three
independent measurements with standard deviations of less than 5%. Solid lines represent linear regression curve ﬁtting using
GraphPad Prism software. TCA cycle, tricarboxylic acid cycle. (C) Synergistic effect of DHCL and mannitol on S. aureus USA300 survival
rates in macrophages. Following bacterial infection and removal of extracellular bacteria by gentamicin treatment, infected RAW 264.7
cells were cultured in either control media (red) or media containing 2.75 mM mannitol (blue). To examine the effect of SaM1PDH
inhibitor, both culture media were supplemented with 0 to 20 M DHCL. CFU levels of internalized bacteria were then determined
by plating infected RAW 264.7 cell lysates onto the BHI agar and plotted against DHCL concentrations on a graph. Data were obtained
from three independent infection experiments and are presented as means (dots) standard deviations of the means (whiskers). Solid
lines connect data points. Statistical signiﬁcance was calculated by Student’s t test (*, P 0.05; **, P 0.01; ***, P 0.001).
TABLE 1 Effects of DHCL on enzymatic kinetic parameters of SaM1PDH F6P reduction
activitya
DHCL concn (M) Km,appb (M) Vmax (A/s) Km,app/Kmc
0 88.6 0.22 1.00
2 104.7 0.21 1.18
4 146.5 0.19 1.65
20 516.8 0.21 5.83
aDHCL, dihydrocelastrol.
bKm,app, apparent Km.
cKm, substrate concentration that yields half-maximal velocity in the absence of inhibitor.
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reductase activity (conversion of F6P to M1P) was highest at a physiological pH (7.2),
whereas dehydrogenase activity (conversion of M1P to F6P) was highest at an alkaline
pH (10.0), thereby supporting our observation that the intracellular mannitol level in
the WT strain at an alkaline pH was lower than that at a neutral pH (Fig. 2B). This may
imply that under such stress conditions, the conversion of M1P to F6P by SaM1PDH is
necessary for boosting energy metabolism (glycolytic pathway), which might provide
an explanation of the growth defect of the knockout strain observed at a high pH
(Fig. 2A).
Third, to explain the growth defect of the knockout strain and the increased
intracellular mannitol level in the WT strain under conditions of salt stress (Fig. 2A and
B), the oxidoreductase activity of SaM1PDH was assessed at various NaCl concentra-
tions (0 to 300 mM) (Fig. 5B). Enzymatic assays revealed that SaM1PDH F6P reduction
activity increased proportionally to the NaCl concentrations and reached a plateau at
200 mM NaCl. In contrast, the M1P oxidation activity of SaM1PDH decreased in a
dose-dependent manner that was dependent on the NaCl concentrations and reached
20% of maximal activity at 200 mM NaCl (Fig. 5B). These results explained why the
intracellular mannitol level was elevated in the WT and complemented strains but not
in the knockout strain when the salt stress was imposed (Fig. 2B). Accordingly, the
knockout mutant could not grow well under conditions of salt stress due to the lack of
osmotic potential regulation.
In general, S. aureus strains are halotolerant and can endure a high concentration of
NaCl (40). To understand the molecular mechanism of salt tolerance, we investigated
the effects of salt stress on the activity of SaM1PDH. It is known that salt stress is directly
linked to pH stress under physiological conditions due to the activity of sodium/
hydrogen exchangers in S. aureus (40, 41). In fact, sodium stress can decrease pHi by the
imported hydrogen ions, which occurs in response to exportation of intracellular
sodium (42, 43). Accordingly, salt treatment could induce the lower pHi (Fig. 1B), which
actually had been observed previously in S. aureus and other Gram-positive bacteria
such as Listeria monocytogenes (40, 41, 44), wherein pHi was decreased upon salt
treatment. Therefore, it is anticipated that under physiological conditions, salt stress not
only would increase the salt concentration but also could reduce pHi. To test the
enzymatic activity of SaM1PDH under such conditions, we examined the F6P reductase
activity in the presence and absence of 200 mM NaCl at various pH levels (Fig. 5C). The
results revealed that F6P reductase activity was optimal at 200 mM NaCl and pH 6.5
(Fig. 5C). This may indicate that the salt endurance of S. aureus under physiological
FIG 5 In vitro characterizations of SaM1PDH enzymatic activities. (A) pH dependence of SaM1PDH oxidoreductase
activities. (B) Salt concentration dependence of SaM1PDH oxidoreductase activities. In the experiments whose
results are presented in panels A and B, M1P oxidation (blue) and F6P reduction activities (red) of SaM1PDH were
measured by monitoring changes in absorbance of NADH at 340 nm under conditions of (A) various pHs (5.0 to
11.5) and (B) various NaCl concentrations (0 to 300 mM). (C) pH dependence of SaM1PDH reductase activity at
200 mM NaCl. F6P reduction activity of SaM1PDH was measured by monitoring changes in absorbance of NADH
at 340 nm in the presence (red) and absence (Ctrl; black) of 200 mM NaCl as a control. In panels A to C,
oxidoreductase activities of SaM1PDH were normalized against the maximal enzymatic capacities (indicated by thin
vertical lines) measured under each set of experimental conditions and are expressed as percent activity. Each
experiment was done in triplicate, and data points were presented as means (dots)  standard deviations of the
means (whiskers). Solid lines connect data points.
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conditions was a consequence of maintaining a high mannitol level through elevated
reductase activity of SaM1PDH at high salt levels and under acidic pH conditions, which
possibly provides a plausible explanation for one of the underlying molecular mecha-
nisms of the high-salt endurance of S. aureus.
Structural insight into the molecular mechanism of stress modulation by
M1PDH. To understand the molecular mechanism of SaM1PDH at the atomic level, we
solved its crystal structure by the multiwavelength anomalous diffraction method. The
ﬁnal structure model was reﬁned to a 1.7-Å resolution with Rwork and Rfree factors of
16.6% and 19.2%, respectively (Table 2). SaM1PDH consists of two domains: (i) an
N-terminal domain (residues 1 to 190) containing 12 -strands (1 to 12) and ﬁve
-helices (1 to 5) and (ii) a C-terminal domain (residues 191 to 368) containing 11
-helices (6 to 16) (Fig. 6A; see also Fig. S7A). In the N-terminal domain, a six-
stranded parallel -sheet (5-2-1-6-7-8) forms a typical Rossmann fold, which is
commonly found in nucleotide-binding proteins (45). This -sheet is extended into two
mixed -sheets (10-11-12 and 9-3-4), which form a barrel surrounding helix 1.
The Gly-rich motif GXGXXG (residues 7 to 12), which is responsible for binding to the
phosphate backbones of NAD and NADH (46, 47), is located in the loop between
strand 1 and helix 1 (Fig. 6A).
To explore the biochemical implications of the presence of SaM1PDH, we then
compared its structure to that of P. ﬂuorescens M2DH (PfM2DH; PDB: 1M2W) in a
complex with its cofactor (NAD) and substrate (mannitol) (24). Individual domains
were found to be well superimposed with the root mean square deviation (RMSD)
TABLE 2 Data collection and reﬁnement statistics
Parameter
SeMet-SaM1PDH resulta
Median Peak Inﬂection Remote
Data collection
Space group P212121 P212121 P212121 P212121
Wavelength (Å) 1.0000 0.9789 0.9792 0.9640
Unit cell
A (Å) 56.7 56.7
B (Å) 58.1 58.1
C (Å) 126.8 126.8
     (°) 90 90
Resolution range (Å) 50–1.7 50–2.7 50–2.7 50–2.7
Multiplicity 6.8 (6.1) 6.8 (6.7) 6.8 (6.7) 6.8 (6.7)
Completeness (%) 98.8 (95.5) 100 (100) 100 (100) 100 (100)
I/(I) 32.7 (3.2) 31.8 (6.1) 31.2 (5.1) 31.2 (5.1)
Rmergeb (%) 7.4 (42.8) 7.9 (38.5) 7.9 (39.9) 8.2 (41.1)
Reﬁnement
Resolution (Å) 29.27–1.70






Average B-factor (Å2) 24.0
No. of protein molecules in asymmetric unit 1
Root mean square deviation from ideal geometry (71)
Bond length (Å) 0.004
Bond angle (°) 0.644





aValues in parentheses refer to the highest resolution shell. Clashscore, the number of all-atom steric clashes per 1,000 atoms.
bRmerge  hkl i |Ii(hkl) 
 I(hkl)|/hkl i Ii(hkl), where Ii(hkl) is the observed intensity and I(hkl) is the average intensity for multiple measurements.
cRwork  F(obs)| 
 |F(calc)/|F(obs)|; Rfree was calculated as described for Rwork, but the calculation was performed for 4.31% of the total reﬂections that were
randomly selected and omitted from reﬁnement. calc, calculated; obs, observed.
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values of 2.3 Å over the N-terminal 184 C atoms and 1.9 Å over the C-terminal 166 C
atoms (Fig. 6B), indicating that the overall folds of the N-terminal and C-terminal
domains are highly conserved between the two structures. However, superimposition
of the two intact structures resulted in an RMSD value of 3.2 Å over 326 C atoms,
FIG 6 Overall structure and catalytic sites of SaM1PDH. (A) Ribbon diagram of SaM1PDH crystal structure. For clarity,
-helices and -strands in the N-terminal domain are colored blue and yellow, respectively; -helices in the C-terminal
domain are colored in a gradient transition from cyan to red; and turns and loops in both domains are colored white.
Consensus motif GXGXXG of the Rossmann fold in the N-terminal domain is shown in a magenta stick model. N and C
termini of SaM1PDH are annotated by N and C, respectively. (B) Structural comparisons of SaM1PDH and PfM2DH (PDB:
1M2W). Structures of SaM1PDH and PfM2DH are superimposed at the (left) N-terminal domains and (right) C-terminal
domains. SaM1PDH and PfM2DH are drawn as blue and orange ribbon diagrams, respectively; for clarity, only -helices
and -strands are shown. Mannitol (Mtl) and NAD molecules bound to PfM2DH are drawn as green and magenta
ball-and-stick models, respectively. This color scheme is used in the remaining panels of this ﬁgure. (C to E) Structural
comparisons of SaM1PDH and PfM2DH at the (C) NAD-binding site, (D) mannitol-binding site, and (E) catalytic triad. In
panels C and D, to predict residues of SaM1PDH involved in NAD and mannitol bindings, structures of SaM1PDH and
PfM2DH are superimposed at the (C) N-terminal domains and (D) C-terminal domains as shown in panel B. Dashed lines
represent hydrogen bonds between atoms in NAD/mannitol and their interacting atoms in PfM2DH. In the experiment
whose results are presented in panel E, to predict the catalytic triad of SaM1PDH, N-terminal and C-terminal domains
of PfM2DH were separated from each other and respectively superimposed on the intact structure of SaM1PDH. (F)
Electrostatic potential surfaces (contouring level of  5 kTe
1) of substrate-binding sites of (left) PfM2DH and (right)
SaM1PDH. Structures of SaM1PDH and PfM2DH are superimposed at their C-terminal domains as shown in panel B.
Electrostatic properties (positive charge, blue; neutral, white; negative, red) were calculated using APBS (68). The
mannitol molecule was intentionally modeled in SaM1PDH structure and is used as a reference for the same view to
represent substrate-binding pockets of SaM1PDH and PfM2DH. Sulfate (yellow) and sulfate-interacting residues (white)
are drawn in ball-and-stickmodels. (G) Structural superimposition of the active sites of SaM1PDH and PfM2DH. Structures
of SaM1PDH and PfM2DH are superimposed shown in panel E. Catalytic triads of SaM1PDH and PfM2DH are highlighted.
Magenta dashed lines represent bonds between SO42– (yellow ball-and-stick representation) and its interacting atoms
in SaM1PDH. Figures were prepared using PyMOL (http://www.pymol.org).
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indicating that the relative orientations of the N-terminal and C-terminal domains are
slightly different between the two structures (Fig. 6B). This might be because of the
absence of the cofactor and substrate in the structure of SaM1PDH.
The structural similarity suggests that SaM1PDH and PfM2DH share similarities in the
cofactor and substrate recognition regions. By means of comparison with the structure
of PfM2DH, we were able to localize the active site of SaM1PDH within an interdomain
pocket where the cofactor (NAD/NADH) and substrate (M1P/F6P) occupy the
N-terminal and C-terminal domains, respectively (Fig. 6C and D). We also identiﬁed the
key residues in the active site of SaM1PDH, most of which are highly conserved in
PfM2DH, as follows: the NAD-binding residues in PfM2DH (Gly36, Phe37, Asp69,
Ile131, Asp190, Asn191, and Thr233) overlapped well those in SaM1PDH (Asn10, Ile11,
Asp31, Val89, Glu118, Asn119, and Val153) (Fig. 6C), and the mannitol-binding residues
in PfM2DH (Lys295, Asn300, His303, Arg373, and Lys381) superimposed well on those
in SaM1PDH (Lys200, Asn205, His208, Arg280, and Lys288) (Fig. 6D). Accordingly, the
catalytic triad in PfM2DH (Asn191, Lys295, and Asn300) is structurally identical to that
in SaM1PDH (Asn119, Lys200, and Asn205) (Fig. 6E), suggesting conservation in the
molecular catalytic mechanisms of PfM2DH and SaM1PDH.
Considering the reported role of each of the catalytic residues in PfM2DH (23, 24),
we assumed that the active site residue Lys200 in SaM1PDH plays the role of a catalytic
base whereas active site residues Asn119 and Asn205 in SaM1PDH are the two
oxyanion hole residues. Depending on the protonation state of the Lys200 side chain,
it can donate a proton in F6P reduction at a slightly acidic pH or accept a proton in M1P
oxidation at an alkaline pH, thereby supporting our observation that in vitro oxi-
doreductase activity of SaM1PDH is pH dependent (Fig. 5).
In addition to the pH-dependent oxidoreductase activity, we also observed salt-
dependent activity of SaM1PDH (Fig. 5). However, to the best of our knowledge, no
study has examined the activity of PfM2DH under conditions of salt regulation. Com-
paring the electrostatic potential surfaces of the active sites of SaM1PDH to those of
PfM2DH, we noticed that the active site cavity of SaM1PDH consists of a larger number
of positively charged residues (Lys200, Arg268, Arg283, Arg287, Lys288, and Arg294)
than that of PfM2DH (Fig. 6F and G). In SaM1PDH, hydrophobic surfaces are contributed
only by Ile152 and Val204. Due to the differential levels of hydrophobicity of M1P and
F6P, we assumed that at a low salt concentration, a condition which increases electro-
static forces, SaM1PDH prefers M1P binding. On the other hand, at a high salt
concentration, a condition which favors hydrophobic interactions, SaM1PDH prefers
F6P binding. This assumption is consistent with and supports our observation of the
salt-dependent in vitro oxidoreductase activity of SaM1PDH (Fig. 5B and C).
Substrate and inhibitor binding mode of SaM1PDH. While PfM2DH recognizes
mannitol and fructose as the substrates, SaM1PDH speciﬁcally recognizes the phos-
phorylated forms (M1P and F6P). Thus, the active site of SaM1PDH is likely to be
different from that of PfM2DH. Accordingly, a structural comparison revealed that the
substrate-binding cavity of SaM1PDH is much wider than that of PfM2DH (Fig. 6F). In
addition, a putative phosphate-binding pocket that was surrounded by three basic
residues (Arg283, Arg287, and Arg294) was identiﬁed in the SaM1PDH structure. High
electron density in the pocket was modeled by SO42-, since a high concentration of
ammonium sulfate was used for the crystallization of SaM1PDH (Fig. 6G). The idea of
the existence of the phosphate-binding pocket is supported by the fact that the three
Arg residues in the pocket are not conserved in M2DHs across bacteria but are strictly
conserved among M1PDHs (Fig. 6G; see also Fig. S7B to E). Moreover, this pocket also
exists in the crystal structure of M1PDH from Shigella ﬂexneri (SfM1PDH; PDB: 3H2Z),
which is superimposed well on the SaM1PDH structure with an RMSD value of 1.46 Å
over 352 C atoms (Fig. S7B to D). In SfM1PDH, the three conserved Arg residues
stabilize a phosphate ion (Fig. S7B to D). Therefore, Arg283, Arg287, and Arg294 in
SaM1PDH are likely to form a structural motif that recognizes the phosphate moiety of
M1P/F6P when these substrates bind to M1PDH (Fig. 6G). Supporting that conjecture,
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the study of docking of M1P and F6P to SaM1PDH revealed that Arg287 and Arg294
play the key roles in binding the phosphate moieties of M1P and F6P whereas Arg283
makes a lesser contribution because it is further from the phosphate moiety than
Arg287 and Arg294 (Fig. 6G; see also Fig. 7A and B). In addition, a molecular docking
analysis of the binding of the DHCL inhibitor to SaM1PDH showed that DHCL likely
binds to the active site in direct competition with substrates at the phosphate-binding
site (Fig. 7C), thereby inhibiting the substrate binding activity and reducing the
SaM1PDH activity. This result is consistent with the competitive inhibition kinetics of
DHCL on SaM1PDH (Fig. 4B). To conﬁrm the structural interpretation presented above,
we generated mutants of SaM1PDH (R283S, R287S, and R294F), and examined their in
vitro enzymatic activities. The catalytic activities of R287S and R294F mutants against
both substrates were signiﬁcantly lower than that of the WT SaM1PDH. This indicates
the indispensability of these two basic residues for SaM1PDH activities and particularly
in substrate recognition (Fig. 8A). In contrast, the catalytic activity of the R283S mutant
was moderately lower than that of the WT enzyme (Fig. 8A). Therefore, the enzymatic
activities of the mutants are consistent with the predicted function of the three
conserved Arg residues in the phosphate binding motif.
To further validate the roles of these Arg residues in vivo, we complemented
the mtlDermr knockout strain with mutants of mtlD (strains mtlDermr_R283S,
mtlDermr_R287S, and mtlDermr_R294F) and examined their mannitol-metabolizing
activities by analysis of the corresponding color changes in mannitol phenol red broth
(Fig. 8B). Consistent with the molecular analysis of enzymatic activities, strains
mtlDermr_R287S andmtlDermr_R294F showed dramatically reduced and completely
lost mannitol-metabolizing activities, respectively; whereas strain mtlDermr_R283S
showed slightly reduced activity compared to the WT strain or the mtlDermr_mtlD
strain (Fig. 8B). The physiological role of M1PDH was further analyzed using the inactive
mutant complementation strain mtlDermr_R294F under conditions of salt, ROS, and
mannitol stresses (Fig. 8C). This experiment conﬁrmed that strain mtlDermr_R294F
showed responses that were nearly identical to those shown by the knockout strain
(Fig. 2B; see also Fig. 8C). In addition, the cell swelling and cytolysis phenotypes of the
mtlDermr_R294F strain were also comparable to those of the knockout strain (Fig. 8D;
see also Fig. S3B and C). Consistently, the survival rate of the mtlDermr_R294F strain
was similar to that of the knockout strain and was signiﬁcantly reduced compared to
that of the WT strain in a RAW 264.7 macrophage infection model in the presence of
mannitol (Fig. 8E). Taken together, these results strongly support the idea that Arg287
and, particularly, Arg294 are important residues in substrate recognition and thereby in
the enzymatic activity of SaM1PDH, which is essential for mannitol metabolism, cell wall
integrity, and stress responses.
DISCUSSION
NAD/NADH-dependent oxidoreductases, M1PDH enzymes were previously found
to be involved in the interconversion of M1P to F6P in the mannitol pathway (21, 48).
However, very little is known about M1PDH owing to the lack of its structural and
functional characterization. In this study, by comparing the mtlD knockout strain with
WT S. aureus USA300 in terms of mannitol catabolism ability and its correlation with
salinity, alkalinity, and ROS susceptibility (Fig. 2), we identiﬁed SaM1PDH as an indis-
pensable stress-alleviating enzyme, which supports the idea of the halophilic nature of
S. aureus strains (49). The pH and ROS stress responses were shown to be essential for
pathogen acclimation under pathophysiological conditions in the host cell (50). The
elevated levels of the intracellular mannitol pool under these stress conditions provide
a meaningful connection to understand how SaM1PDH and mannitol play a role in
protecting bacteria from these stresses in the host (Fig. 2; see also Fig. 3).
After establishing the indispensability of SaM1PDH in protection against salt/pH and
ROS in S. aureus, we proposed SaM1PDH as a critical potential target for antibacterial
therapeutics and substantiated the proposal by providing several lines of evidence.
First, we described the basis of a new bactericidal strategy for S. aureus by mannitol-
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FIG 7 Structural docking models of SaM1PDH in complexes with (A) mannitol-1-phosphate, (B) fructose-6-phosphate, and (C) dihydrocelastrol. Mannitol-1-
phosphate (M1P), fructose-6-phosphate (F6P), and dihydrocelastrol (DHCL) were docked into the ligand-binding pocket of SaM1PDH using UCSF Chimera (69),
and only the docked chemical-SaM1PDH complexes with the best binding energy scores were selected for analyses. (Left panels) Electrostatic potential surface
(contouring level of  8 kTe
1) at the ligand-binding pocket. Electrostatic properties (positive charge, blue; neutral, white; negative, red) were calculated using
APBS (68). Structures of SaM1PDH and docked chemicals are shown as surface representations and magenta ball-and-stick models, respectively. (Middle panels)
Predicted important residues of SaM1PDH involved in interactions with the docked chemicals. Chemicals and SaM1PDH residues are represented as magenta
and white ball-and-stick models, respectively. Hydrogen and ionic bonds are represented by yellow dashed lines between interacting atoms. For clarity, the
ligand-binding pocket of SaM1PDH is shown as transparent electrostatic potential surfaces. (Right panels) Two-dimensional schematic diagram illustrating
interactions of SaM1PDH and docked chemicals. Chemicals and SaM1PDH residues predicted to interact with the docked chemicals are represented as magenta
and black ball-and-stick diagrams, respectively (carbon atom, black; oxygen, red; nitrogen, blue; phosphorus, purple). Hydrogen and ionic bonds are visualized
as blue dashed lines between interacting atoms, and bond distances are indicated in angstrom (Å) values. Residues involved in hydrophobic interactions with
the docked chemicals are visualized as brown arcs with spokes toward the contacting atoms in the chemicals. Figures were prepared by using PyMOL
(http://www.pymol.org) and LigPlot v.2.1 (70).
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derived cytolysis in the absence/inhibition of SaM1PDH activity. The presence of
extracellular mannitol led to mannitol uptake through a PTS as reported earlier (21, 51,
52) and subsequently resulted in its accumulation due to the absence of SaM1PDH
activity under mtlD knockout conditions (Fig. 2B). Moreover, the lack of SaM1PDH
activity was observed to induce the expression the PTS (see Fig. S2B in the supple-
mental material), which further enhanced the intracellular mannitol pool, causing the
inﬂow of excess water, cell swelling, and cytolysis (Fig. 2). It is noteworthy that mannitol
or the factors (high salt, glucose, etc.) that could enhance the intracellular mannitol
pool have been shown to potentiate antibiotics (-lactam, aminoglycosides), leading to
susceptibility of Escherichia coli (53), Pseudomonas aeruginosa bioﬁlms (54), and S.
aureus persisters (22). Mannitol has previously been shown to potentiate antibiotics by
generating a proton-motive force (PMF) (22, 50). Therefore, mannitol metabolism seems
to play an essential role in antibiotics potentiation by modulating the electrochemical
FIG 8 Mutational analysis of the SaM1PDH phosphate-binding site. (A) In vitro enzymatic activities of SaM1PDH mutants.
Catalytic activities (left, M1P dehydrogenase; right, F6P reductase) of WT and mutant SaM1PDH were examined by
measuring changes in absorbance of NADH at 340 nm in a time-dependent manner. Oxidoreductase activities were
normalized against the maximal enzymatic activity of WT SaM1PDH and expressed as percent activities. (B) Mannitol-
metabolizing activities of WT and mutant S. aureus USA300 strains. The indicated bacterial strains were cultured in the
mannitol salt broth containing phenol red as a pH indicator in a 96-well plate. The plate was photographed after overnight
incubation at 37°C. Failure to change broth to yellow indicates a negative mannitol fermentation result. For clarity, the
relative levels of red coloring of the culture broth were quantiﬁed by densitometric analysis and plotted against S. aureus
strains on a graph (shown above the photographs of culture wells). (C) Effects of various stress conditions on intracellular
mannitol levels in S. aureus USA300 strains. The indicated bacterial strains were cultured in either BHI media (control [Ctrl])
or modiﬁed BHI media mimicking stress conditions (200 mM NaCl, ROS, and 27.5 mM mannitol). Intracellular mannitol was
then extracted and quantiﬁed, and the levels were calculated as percentages of mannitol in S. aureus USA300 strains grown
under various conditions compared to that of the WT strain grown in control media. (D) Effect of mannitol on colony
morphologies of WT and mutant S. aureus USA300 strains. The indicated bacterial strains were spotted onto the BHI agar
containing 27.5 mM mannitol. Plates were photographed after incubation at 37°C for 48 h. (E) Effect of mannitol on
susceptibilities of WT and mutant S. aureus USA300 strains in macrophage infection assays. After infections by WT,
mtlDermr_mtlD, and mtlDermr_R294F S. aureus USA300 strains followed by removal of extracellular bacteria, infected
RAW 264.7 cells were cultured in media supplemented with 2.75 mM mannitol for 6 h. CFU levels of internalized bacteria
were then determined by plating infected RAW 264.7 cell lysates onto BHI agar. All experiments were done in at least three
independent replicates, and data were presented as means standard deviations of the means. Statistical signiﬁcance was
calculated by Student’s t test (*, P 0.05; **, P 0.01; ***, P 0.001; NS, not signiﬁcant).
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gradient. However, the use of antibiotics even at lower concentrations could induce the
antibiotic resistance (55). This study demonstrated an antibiotics-free alternative anti-
bacterial approach wherein inhibition of the SaM1PDH activity of mannitol metabolism
followed by mannitol treatment induces the cytolysis of S. aureus cells.
Second, we demonstrated the higher susceptibility of the mtlD knockout strain and
the effect of mannitol both in an in vitromurine macrophage infection model and in an
in vivo murine infection model. The enhanced susceptibility of the S. aureus strain
lacking SaM1PDH activity in the mtlD knockout strain is presumably caused by (i)
imbalance in mannitol homeostasis due to the absence/inhibition of SaM1PDH activity
resulting in the reduced ROS resistance potential of S. aureus and (ii) accumulation of
mannitol resulting in inﬂow of water and cytolysis of S. aureus inside the host. (Fig. 3).
Therefore, it is conceivable that a S. aureus strain devoid of SaM1PDH activity due to
either the absence of the mtlD gene or its inhibition would be extremely susceptible to
host-imposed stresses, especially upon mannitol treatment.
Finally, we have shown that our proposed strategy could be implemented by a
small-molecule inhibitor of SaM1PDH. We exempliﬁed the strategy by using a novel
competitive inhibitor of SaM1PDH, DHCL (Fig. 4; see also Fig. 7), which synergistically
decreased the survival of S. aureus with mannitol treatment in an in vitro macrophage
infection model (Fig. 4).
Mannitol was identiﬁed as one of the dominant compatible solutes in a wide
spectrum of Pseudomonas putida strains and in Gluconobacter oxydans and is consid-
ered to play a role in osmoprotection during high-salt stress (10, 12). However, the
molecular mechanism of stress modulation by mannitol is not well established. In this
study, by investigating the molecular mechanism of directionality in SaM1PDH, we
established a theory of the switching activity of SaM1PDH being dependent upon
intracellular pH (pHi) and the salt concentration to maintain the osmotic pressure
(Fig. 2B; see also Fig. 5). At lower pHi or under conditions of high salt concentrations,
SaM1PDH favors the biosynthesis of mannitol from fructose-6-phosphate, which causes
water inﬂow. In contrast, at higher pHi or under conditions of low salt concentrations,
SaM1PDH favors the reverse direction, i.e., catabolism of mannitol, inducing water
outﬂow (56). Interestingly, salt stress is known to decrease pHi in bacteria (40–43),
indicating connections among pHi, high-salt stress, and the regulation of mannitol
metabolism and homeostasis involving SaM1PDH.
In the conventional mannitol metabolism cycle, two dehydrogenases (M1PDH and
M2DH) are responsible for intracellular mannitol metabolism (18). However, the man-
nitol metabolism in bacteria seems to involve only a single dehydrogenase, i.e., either
M1PDH or M2DH (see Table S1 in the supplemental material). The structure, function,
and catalytic activity of M2DH have been well characterized (23–25). However, the
differences in substrate recognition and speciﬁcity between these two enzymes re-
mained unknown. In this study, our atomic resolution structure of SaM1PDH (1.7 Å) and
its structural comparison with that of PfM2DH in complex with mannitol and NAD
provided structural insights into such differences in substrate recognition and speci-
ﬁcity (23–25). The substrate-binding site of SaM1PDH is located in the interdomain
interface as found in PfM2DH. The SaM1PDH substrate-binding cavity is larger than that
of PfM2DH and is highly positively charged owing to the presence of arginine residues
R283, R287, and R294. These three Arg residues appear to be necessary for the
recognition of the phosphate moiety as they are located at the expected position of the
phosphate moiety-binding pocket and are highly conserved with respect to M1PDH
among bacteria (Fig. 6; see also Fig. S7B to E). The role of the three arginine residues
in the SaM1PDH substrate-binding cavity was further corroborated by docking analysis
and mutational validation of SaM1PDH (Fig. 8). Interestingly, the docking study results
also suggested that the competitive inhibitor of SaM1PDH, DHCL, would also bind the
phosphate moiety-binding pocket and thereby competes with the substrates to block
the SaM1PDH activity (Fig. 7).
In conclusion, by applying comprehensive structural, biochemical, and physiological
approaches, we found that SaM1PDH performs as a molecular switch between energy
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provision and osmotic pressure maintenance depending on external cues such as pH,
salt, and redox status, which control SaM1PDH activities and directionality for mannitol
consumption or biosynthesis. We also suggest that the antibacterial effect of the
SaM1PDH inhibitor can be enhanced when combined with the presence of mannitol.
To the best of our knowledge, this is the ﬁrst report demonstrating that SaM1PDH acts
as a potent antibacterial target by the activity of its mechanism and identifying its
speciﬁc inhibitor, DHCL. Indispensability, ubiquity, and uniqueness in a wide range of
S. aureus strains (Table S1) make SaM1PDH a potent antibacterial and an antivirulence
target and thus plausibly effective in the treatment of multidrug-resistant S. aureus
infections.
MATERIALS AND METHODS
Supplemental materials and methods. Additional descriptions of materials and methods used in
this study are presented in Text S1 in the supplemental material.
Materials. All chemicals used in this study were purchased from Sigma-Aldrich (St. Louis, MO, USA)
unless speciﬁed otherwise. When necessary, bacterial growth media were supplemented with appropri-
ate antibiotics at the following working concentrations: kanamycin 30 g/ml and ampicillin 100 g/ml
for Escherichia coli and chloramphenicol 25 g/ml and erythromycin 10 g/ml for Staphylococcus aureus.
The primers (Bioneer Corporation, South Korea), plasmids, and bacterial strains used in this study are
listed in Table S2 in the supplemental material. The murine macrophage RAW 264.7 cell line (ATCC
TIB-71) was purchased from the American Type Culture Collection (ATCC, USA) and maintained following
the supplier’s instructions.
Methods. (i) Staphylococcus aureus cell growth assays performed under abiotic stress condi-
tions. To generate the abiotic stresses, the brain heart infusion (BHI) media were modiﬁed as follows: (i)
to mimic an alkaline condition, the BHI media were adjusted to a pH of 10.0 by addition of NaOH; (ii) to
mimic a high-osmoticity condition, the BHI media were supplemented with 0.2 M NaCl. After an
overnight culture in the unmodiﬁed BHI media at 37°C, the S. aureus cultures were diluted to an optical
density at 600 nm (OD600) of 0.05 in either unmodiﬁed BHI media or modiﬁed BHI media mimicking
abiotic stresses. Bacterial suspensions were then divided into aliquots (200 l) and placed into each well
of 96-well plates, and the plates were incubated at 37°C. The cell growth was monitored by measuring
the OD600 at 1-h intervals for 16 h on an Inﬁnite M200 Microplate Reader (Tecan, USA) or by quantifying
the number of bacteria by CFU assays at 5-h intervals for 15 h.
(ii) Determination of the intracellular mannitol levels using a colorimetric assay. To determine
the accumulations of the intracellular mannitol in S. aureus strains under conditions of various abiotic
stresses, S. aureus strains were grown at 37°C for 6 h in either BHI media or modiﬁed BHI media mimicking
the stress conditions as follows: (i) BHI media were adjusted to a pH of 10 by addition of NaOH; (ii) BHI
media were supplemented with 0.2 M NaCl; (iii) BHI media were supplemented with ROS-generating
chemicals (50 M H2O2, 10 M FeSO4, and 10 M NaI); (iv) BHI media were supplemented with 27.5 mM
D-mannitol. After two washes with phosphate-buffered saline (PBS), a 100-mg volume of bacterial cell
pellets was treated with 5 units of lysostaphin at 37°C for 30 min in a 0.5-ml volume of buffer containing
40 mM Tris-HCl (pH 7.5), 3.5 mM EDTA, and 5.0 mM cysteine hydrochloride. A 1-ml volume of a
phenol-chloroform (1:1) mixture was then added into the bacterial cell lysates to separate proteins, lipids,
and water-insoluble metabolites from water-soluble metabolites. Because mannitol is much more soluble
in water than in organic solvents, the intracellular mannitol prefers residing in the aqueous phase rather
than in the organic phase. After vortex mixing was performed for 2 min, the mixtures were centrifuged
at 9,300	 g for 10 min at room temperature, and the top aqueous layers were carefully collected.
Following a passage of the collected aqueous layers through a mixture (1:1) of strong cation-exchange
resins (Dowex 50WX4; hydrogen form, 100 to 200 mesh) and strong anion-exchange resins (Dowex 1X8;
chloride form, 200 to 400 mesh), the eluents containing neutral sugars were recovered and subjected to
a colorimetric assay of mannitol as described by Sanchez (57). Brieﬂy, mannitol in the eluents was
speciﬁcally oxidized by periodate at a pH of 3.0 in the presence of acetylacetone, ammonium acetate,
and sodium thiosulfate. After heating the reaction mixtures at 100°C for 2 min, the intracellular mannitol
level was determined by measuring the absorbance of the resultant yellow color at 412 nm on a model
V-750 spectrophotometer (Jasco, Japan).
(iii) Triton X-100-induced autolysis assays. Overnight BHI cultures incubated at 37°C of S. aureus
strains were diluted in the BHI media to an OD600 of 0.05. Bacteria (10 l) were then spotted onto either
BHI agar or BHI agar containing 27.5 mM mannitol. After incubation at 37°C for 48 h, bacterial spots were
scraped from the agar surfaces and suspended in PBS. Following two washes with PBS, bacterial
suspensions were diluted to an OD600 of 0.9 in PBS containing 0.05% Triton X-100, and 200-l volumes
of the suspensions were divided into aliquots and placed into each well of a 96-well plate. Cell lysis were
examined by monitoring the OD600 at 2-h intervals for 12 h at room temperature on an Inﬁnite M200
Microplate Reader (Tecan, USA) or by quantiﬁcation of the surviving bacterial counts by CFU assays at
intervals of 4 h for 12 h.
(iv) S. aureus cell morphology assays using scanning electron microscope (SEM) analysis. The
WT and SaM1PDH knockout (mtlDermr) S. aureus strains were grown at 37°C for 48 h in either BHI media
or BHI media supplemented with 5 mM mannitol. After three washes with PBS, S. aureus cells were ﬁxed
with 2% glutaraldehyde–PBS for 12 h at room temperature. The cells were then gradually dehydrated in
10%, 20%, 30%, 50%, 70%, and 90% ethanol at room temperature for 5 min at each ethanol concentra-
M1PDH as a Novel Antimicrobial Target ®
July/August 2019 Volume 10 Issue 4 e02660-18 mbio.asm.org 19
tion and ﬁnally suspended in the absolute ethanol. After adjustment of the cell densities to an OD600 of
1.0 in absolute ethanol, 10-l volumes of the cell suspensions were placed on the silicon wafer substrates
and air dried. Following sputtering performed with platinum, air-dried specimens were observed on a
JSM-6390A scanning electron microscope (JEOL, Japan) with an accelerating voltage of 15 kV at a
working distance of 10.1 mm and a magniﬁcation of 	30,000. The relative diameters of 40 to 100
bacterial cells that were randomly selected from each S. aureus strain appearing the SEM photographs
were measured using ImageJ software (58).
(v) SaM1PDH oxidoreductase activity assays. In a typical reaction, a 13 nM concentration of either
puriﬁed WT or mutant SaM1PDH was incubated with a 13 M concentration of a substrate (mannitol-
1-phosphate [M1P] or fructose-6-phosphate [F6P]) and a 200 mM concentration of a corresponding
cofactor (NAD or NADH) in a reaction volume of 200 l in 96-well plates. The dehydrogenase and
reductase activities of SaM1PDH were determined by measuring the changes in the absorbance of NADH
at 340 nm on an Inﬁnite M200 Microplate Reader (Tecan, USA) after 10 min of incubation at room
temperature unless otherwise stated.
To examine SaM1PDH oxidoreductase activities in a time-dependent manner, the reactions were
carried out in buffers containing 25 mM HEPES (pH 7.5). To examine the salt concentration dependences
of SaM1PDH oxidoreductase activities, the reactions were carried out in buffers containing 25 mM HEPES
and 0 to 300 mM NaCl. To examine the pH dependences of SaM1PDH oxidoreductase activities, the
reactions were carried out in different buffers as follows: 25 mM MES (morpholineethanesulfonic acid) at
pH 5.0 to 7.0, 25 mM HEPES at pH 7.5 to 8.5, 25 mM CHES [2-(cyclohexylamine)ethanesulfonic acid] at pH
8.5 to 10.0, and 25 mM CAPS (N-cyclohexyl-3-aminopropanesulfonic acid) at pH 10.0 to 11.0. These
reaction buffers, supplemented with 200 mM NaCl, were used to examine the effects of both NaCl and
pH on the F6P reductase activity of SaM1PDH.
(vi) Macrophage infection assays. Prior to the S. aureus infection, the murine macrophage RAW
264.7 cells were cultured in low-glucose Dulbecco’s modiﬁed Eagle’s medium (DMEM) (Welgene, South
Korea) supplemented with 10% fetal bovine serum (FBS) (Welgene, South Korea). The S. aureus cells, after
being cultured overnight, were harvested by centrifugation (4,000 rpm for 5 min), followed by three
washes in cold PBS. The bacterial cells were resuspended in DMEM and were then used to infect RAW
264.7 cells at a multiplicity of infection (MOI) of 100:1 (30–32) at 37°C in a CO2 incubator (5% CO2) for
30 min. To kill the extracellular S. aureus in a GPA, infected RAW 264.7 cells were treated with 100 g/ml
gentamicin for 1 h at 37°C in a CO2 incubator. Following two washes with DMEM, the infected RAW 264.7
cells were continuously incubated with DMEM containing 2.75 mM mannitol and 100 g/ml gentamicin
for 6 h at 37°C in a CO2 incubator. To examine the synergistic effect of dihydrocelastrol (DHCL) and
mannitol on S. aureus strains infecting the macrophages, the culture media were further supplemented
with various concentrations (0 to 20 M) of DHCL. After three washes with PBS, infected RAW 264.7 cells
were lysed in PBS containing 0.05% Triton X-100. The RAW 264.7 cell lysates were serially diluted and
plated onto the BHI agar to enumerate the internalized S. aureus cells. To validate the GPA-based data,
the enzyme protection assay (EPA) was performed in parallel wherein host-cell impermeable lysostaphin
was used to kill extracellular S. aureus (33) (Fig. S4A).
(vii) Murine model of systemic infection. The WT and M1PDH knockout (mtlDermr) S. aureus
strains were grown in tryptic soy broth (TSB) at 37°C overnight with shaking. The cell cultures were then
diluted 1:100 into the fresh TSB and allowed to grow at 37°C until the cultures reached an OD600 of 0.8.
Bacterial strains were collected by centrifugation, washed thrice, and suspended in PBS. A total of 100
l of the bacterial cell suspension (2	 107 CFU) was administered intravenously via retro-orbital
injection into each of 15 sex-matched 8-week-old C57BL/6 mice. Subsequently, the same volume of
either PBS or PBS containing mannitol was injected intravenously into these mice at 12-h intervals during
the course of the experiment. Mice were monitored for survival over 8 days. Subsequently, the surviving
mice were subjected to organ isolation, followed by the estimation of bacterial colonization in kidney
and liver by CFU assay. The experiment was carried out in strict accordance with the recommendations
in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The survival
curves were compared using a log rank (Mantel-Cox) test, and the statistical signiﬁcance of results of
comparisons of the levels of bacterial burdens in the indicated organs was determined using the F-test
with GraphPad Prism 6.
(viii) Determination of kinetic parameters for SaM1PDH oxidoreductase activity. Determina-
tions of the Michaelis-Menten kinetic parameters of SaM1PDH oxidoreductase activity followed the
procedure described above for examining the time-dependent SaM1PDH enzymatic activities with the
following modiﬁcations. For the reductase activity, puriﬁed SaM1PDH was incubated at a concentration
of 0.1 ng/ml with 200 mM NADH and various concentrations (0 to 450 M) of F6P. For the oxidase
(dehydrogenase) activity, puriﬁed SaM1PDH was incubated at a concentration of 30 ng/ml with 200 mM
NAD and various concentrations (0 to 250 M) of M1P. At each substrate concentration, initial
enzymatic velocity was determined after a 1-min reaction at 30°C by measuring the change in the
absorbance of NADH in the reaction mixture with substrate compared to that in the control reaction
without substrate and expressed as absorbance change per second (A/s). Graphs were constructed by
plotting the initial enzymatic velocities against the substrate concentrations. The Michaelis-Menten
kinetic parameters, Km and Vmax, were calculated from a nonlinear regression curve-ﬁtting analysis using
GraphPad Prism 6.
To examine the effect of dihydrocelastrol (DHCL) on the Michaelis-Menten kinetic parameters of F6P
reductase activity, reactions were done that were similar to those described above but that were
performed in the presence of various DHCL concentrations (0 to 20 M). After calculation of the initial
enzymatic velocity at each substrate and inhibitor concentration, a double reciprocal Lineweaver-Burk
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plot of the initial reaction rates versus the F6P concentrations was constructed at each DHCL concen-
tration. The apparent Michaelis-Menten kinetic parameters, Km
app and Vmax
app , were calculated from a linear
regression curve-ﬁtting analysis using GraphPad Prism 6. The data are summarized in Table 1.
(ix) Protein crystallization. In a hanging-drop vapor diffusion setup, drops containing 1 l of
selenomethionine (SeMet)-SaM1PDH at a concentration of 35 mg/ml and 1 l of a crystallization reagent
[1.8 M (NH4)2SO4, 0.1 M cacodylate pH 6.5, and 0.01 M CoCl2] were equilibrated against 0.5 ml of the
reagent reservoir at 22°C. Diffraction-quality crystals of SeMet-SaM1PDH were obtained after 1 month.
(x) Data collection and structure determination. Before exposure to the X-ray beam, crystals were
soaked in the crystallization reagent containing 20% glycerol and ﬂash-frozen in a cold nitrogen stream.
All data were collected at beamline 4A of the Pohang Accelerator Laboratory (PAL; South Korea) and
processed using the HKL-2000 program package (59). A multiwavelength anomalous diffraction (MAD)
data set was collected from a single SeMet-SaM1PDH crystal at a resolution of 2.7 Å at three wavelengths
(peak, 0.9789 Å; inﬂection, 0.9792 Å; remote, 0.9640 Å). A 1.7-Å data set collected from another single
SeMet-SaM1PDH crystal at a wavelength of 1.0 Å was used for the reﬁnement of the ﬁnal model. Data
collection statistics are summarized in Table 2.
The positions of four selenium atoms were determined, and an initial map was calculated from the
MAD data set using the SOLVE program (60). The density modiﬁcations were carried out using the
RESOLVE program (61, 62), and approximately 80% of SaM1PDH residues were automatically built into
the density-modiﬁed map. This incomplete model was then used as a search template for molecular
replacement against the 1.7-Å data set using the MOLREP program (63). The automatic model building
was then performed using ARP/wARP software (64) with the MOLREP solution as the input. The manual
model building and correction were conducted using COOT software (65), followed by reﬁnement using
the PHENIX package (66). The ﬁnal model consisted of all 369 amino acids (residues 1 to 368), with an
R factor and Rfree factor of 16.55% and 19.15%, respectively. The structural validation performed using the
MolProbity program (67) showed that the ﬁnal structure had an excellent stereochemistry with no
residues lying in disallowed regions of the Ramachandran plot. The structural reﬁnement and validation
data are summarized in Table 2. All structural ﬁgures were generated using PyMOL (http://www.pymol
.org).
(xi) Mannitol fermentation assays. Examination of the mannitol-metabolizing capacities of differ-
ent S. aureus strains followed the procedure described above for the primary screening assay to identify
the inhibitor hits of SaM1PDH but was performed in the absence of DMSO and the natural compounds.
After the plates were photographed, the levels of red coloring of the mannitol salt broths were relatively
quantiﬁed for each strain using ImageJ software (58).
(xii) Statistical analyses. All experiments were done in at least two independent replicates. Unless
otherwise mentioned, statistical signiﬁcance differences between the sample groups were determined
by Student’s t test (*, P 0.05; **, P 0.01; ***, P 0.001; NS, not signiﬁcant).
(xiii) Data availability. The coordinates and structure factor of S. aureus M1PDH have been
deposited in the Protein Data Bank under accession code 5JNM.
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